709 filings
Page 5 of 36
8-K
8zt4nraj
13 May 21
Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update
4:03pm
8-K
u4cb98bh0z7g5
11 May 21
Viveve Announces Adjournment of Annual Meeting
12:34pm
DEFA14A
4ikcq0zpeco72iy
11 May 21
Additional proxy soliciting materials
12:32pm
424B3
2db0u7 k0dsbdzs56
20 Apr 21
Prospectus supplement
4:49pm
EFFECT
do05o 9m5lfexkx7
20 Apr 21
Notice of effectiveness
12:15am
CORRESP
eu6sjp303g7ejg
15 Apr 21
Correspondence with SEC
12:00am
UPLOAD
6d0w wc7nrkv
7 Apr 21
Letter from SEC
12:00am
8-K
nqkgr4
1 Apr 21
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
8:29am
8-K
h0pn6xubds
31 Mar 21
Entry into a Material Definitive Agreement
4:20pm
S-8
47oyyo
31 Mar 21
Registration of securities for employees
4:18pm
8-K
m5p5g0wyav 84hgr1
18 Mar 21
Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update
4:03pm
8-K
dv81l
18 Feb 21
Viveve Announces Preliminary Topline Financial Results for Fourth Quarter 2020
4:03pm
8-K
jqyg q1rwbym
2 Feb 21
Viveve Announces Expansion of IP Portfolio with Issuance of S. Korean Patent
8:29am
8-K
marfl6ld
21 Jan 21
Viveve Announces Initiation of Pivotal U.S. PURSUIT Trial in Stress Urinary Incontinence
8:29am
8-K
6pmk6
19 Jan 21
Viveve Announces Closing of an Upsized $27.6 Million Underwritten Public Offering and Exercise of Over-allotment Option
4:16pm
424B4
llnr6r86qnqcb8
14 Jan 21
Prospectus supplement with pricing info
5:04pm
EFFECT
rumbfy3x7w8hh 5qg4
14 Jan 21
Notice of effectiveness
12:15am